Back to companies
Dianthus Therapeutics, Inc. /DE/
DNTHUSNASDAQPharmaceuticals & HealthcareDianthus Therapeutics, Inc. /DE/
Revenue
$2.0mn
YoY -67.3%
Operating income
-$177.9mn
FY2025
Employees
—
Founded
—
Source: U.S. Securities and Exchange Commission (SEC) EDGAR Company Facts API